Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Psychopharmacology
|
January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate
K K Midha, J W Hubbard, S R Marder, et al.
Archives of General Psychiatry
|
April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia
S R Marder, W C Wirshing, T Van Putten, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Fluphenazine plasma levels and clinical response
S R Marder, T Van Putten, M Aravagiri, et al.
The American Journal of Psychiatry
|
May 1, 1994
Optimal drug and behavior therapy for treatment-refractory schizophrenic patients
R P Liberman, T Van Putten, B D Marshall, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1991
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response
S R Marder, K K Midha, T Van Putten, et al.
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
The Journal of Nervous and Mental Disease
|
March 1, 1976
Predicting individual responses to drug treatment in schizophrenia: a test dose model
P R May, T Van Putten, C Yale, et al.
Psychopharmacology Bulletin
|
January 1, 1986
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate
S R Marder, J W Hubbard, T Van Putten, et al.
Respiratory Care
|
March 6, 2023
Development of a Reusable Metal 3D-Printed Heat and Moisture Exchanger
Maartje Leemans, Maarten Ja van Alphen, Sara H Muller, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Anticholinergic effects on memory: benztropine vs. amantadine
T Van Putten, A J Gelenberg, P W Lavori, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Psychopharmacology
|
January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate
K K Midha, J W Hubbard, S R Marder, et al.
Archives of General Psychiatry
|
April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia
S R Marder, W C Wirshing, T Van Putten, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Fluphenazine plasma levels and clinical response
S R Marder, T Van Putten, M Aravagiri, et al.
The American Journal of Psychiatry
|
May 1, 1994
Optimal drug and behavior therapy for treatment-refractory schizophrenic patients
R P Liberman, T Van Putten, B D Marshall, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1991
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response
S R Marder, K K Midha, T Van Putten, et al.
Psychopharmacology
|
January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
S R Marder, E M Hawes, T Van Putten, et al.
The Journal of Nervous and Mental Disease
|
March 1, 1976
Predicting individual responses to drug treatment in schizophrenia: a test dose model
P R May, T Van Putten, C Yale, et al.
Psychopharmacology Bulletin
|
January 1, 1986
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate
S R Marder, J W Hubbard, T Van Putten, et al.
Respiratory Care
|
March 6, 2023
Development of a Reusable Metal 3D-Printed Heat and Moisture Exchanger
Maartje Leemans, Maarten Ja van Alphen, Sara H Muller, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Anticholinergic effects on memory: benztropine vs. amantadine
T Van Putten, A J Gelenberg, P W Lavori, et al.
Page
of 11